
Sonio, a wholly-owned subsidiary of Samsung Medison Co., Ltd since 2024, is a highly customizable workflow and practice management solution powered by AI for automation, efficiency, and quality control. "Sonio AI-enhanced¹ software empowers ultrasound practitioners and readers. Sonio assists them in performing every prenatal examination to their highest quality standards, ensuring the completeness of each examination, streamlining their workflow, and in prenatal diagnosis. Sonio is based on over five years of research and collaboration between leading experts in fetal medicine and AI. ¹AI-enhancement is provided by FDA 510(k) cleared Sonio Detect product * Applicable to V1 only, Data enclosed at Sonio **See table 6 in the 510k summary: https://www.accessdata.fda.gov/cdrh_docs/pdf24/K240406.pdf

Sonio, a wholly-owned subsidiary of Samsung Medison Co., Ltd since 2024, is a highly customizable workflow and practice management solution powered by AI for automation, efficiency, and quality control. "Sonio AI-enhanced¹ software empowers ultrasound practitioners and readers. Sonio assists them in performing every prenatal examination to their highest quality standards, ensuring the completeness of each examination, streamlining their workflow, and in prenatal diagnosis. Sonio is based on over five years of research and collaboration between leading experts in fetal medicine and AI. ¹AI-enhancement is provided by FDA 510(k) cleared Sonio Detect product * Applicable to V1 only, Data enclosed at Sonio **See table 6 in the 510k summary: https://www.accessdata.fda.gov/cdrh_docs/pdf24/K240406.pdf
Founded: 2020 (Paris)
Product: AI-enabled prenatal ultrasound workflow software (Sonio Detect)
Regulatory status: Sonio Detect: FDA 510(k) clearance and CE marked
Exit / M&A: Acquired by Samsung Medison in 2024
Recent funding: Series A $14M (2023)
Prenatal ultrasound quality, workflow automation, and reporting in OB-GYN practice.
2020
Software Development
€5,000,000
Announced June 2022
€10,000,000
Reported as €2.5M grant + €7.5M equity
$14,000,000
Participation from Elaia, Bpifrance, OneRagtime and angel investors
Company became a wholly-owned subsidiary of Samsung Medison
“Includes institutional backers (Cross Border Impact Ventures, Elaia, Bpifrance, OneRagtime) and EIC support”
| Company |
|---|
Sonio is dedicated to improving women's and children's health by promoting access and quality of care through technological innovation, medical expertise, and collective intelligence. Each year, 140 million children are born, with birth defects affecting 1 in 33 births in developed countries. In 50% of cases, these defects are not detected during prenatal examinations. Prenatal medicine is complex, and scans can impose heavy responsibilities on healthcare professionals, often causing stress for future parents.
Resulting from five years of collaboration between world-renowned experts from Necker Hospital and Ecole Polytechnique, Sonio utilizes artificial intelligence to enhance prenatal screening and diagnosis. With patented algorithms and a proprietary expert database, Sonio aims to be the reference tool for practitioners, improving screening, reducing diagnostic errors, and optimizing the medical path for pregnant women.
Job Title: VP of Engineering
Location: Paris, Île-de-France, France
Employment Type: Full-time
Department: Engineering